• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

China Medical to Announce Fourth Quarter and Full Year Financial Results for the Year Ended March 31 2006 on June 16, 2006

Posted on: Monday, 24 April 2006, 09:02 CDT

China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets high intensity focused ultrasound products and advanced in-vitro diagnostic systems, plans to release its fourth quarter and full year results for the year ended March 31, 2006 before the market opens on June 16, 2006. The Company will host a conference call on June 16, 2006 at 9:00AM, Eastern Time, to discuss the results.

For the fiscal year ended March 31, 2006, the Company expects net annual revenue to be between RMB 360 million and RMB 400 million, a projected annual growth rate of 65.4% - 83.8%, and net income to be between RMB 175 million and RMB 190 million, a projected annual growth rate of 47.7% - 60.4%. This is the same guidance given by the Company at its third fiscal quarter results announcement on February 13, 2006.

For the conference call, Mr. Sam Tsang, Chief Financial Officer and Mr. Charles Zhu, Vice President, of the Company will review the results and take questions.

CONFERENCE CALL

China Medical's management team will host a conference call at 9:00AM Eastern DST Time on June 16, 2006 (or 9:00PM June 16, 2006 in the Beijing/HK time zone) following this earnings announcement.

The conference call will be available live via webcast at: www.chinameditech.com. A replay of the webcast will be available for one month on this website.

The dial-in details for the live conference call: U.S. Toll Free Number +800-260-8140, International dial-in number +1-617-614-3672; Passcode CMEDCALL.

A telephone replay of the call will be available after the conclusion of the conference call through June 17, 2006. The dial-in details for the replay: U.S. Toll Free Number +888-286-8010, International dial-in number +1-617-801-6888; Passcode 16640453.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will,""expects,""anticipates,""future,""intends,""plans,""believes,""estimates" and similar statements. Among other things, management's expectations of projected financial results in this press release contain forward-looking statements. China Medical may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission on Forms 20-F and 6-K, etc., in its annual report to shareholders, in press releases and other written materials and in oral statements to third parties made by its officers, directors or employees. Statements that are not historical facts, including statements about China Medical's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, China Medical's dependence on its core product, the HIFU therapy system; China Medical's limited operating history; China Medical's dependence on a small number of distributors for a significant portion of its revenues; fluctuations in quarterly operating results; failure to remain competitive in the industries in which it operates; and other risks outlined in China Medical's filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1. China Medical does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About China Medical Technologies, Inc.

China Medical Technologies, Inc. is a China-based medical device company that develops, manufactures and markets products in China using HIFU, for the treatment of solid cancers and benign tumors. China Medical believes that it is a leader in the design and development of HIFU tumor therapy devices in China. In addition, China Medical believes that it is the first China-based company to offer an advanced in-vitro diagnostics system, or IVD system, using enhanced chemiluminescence, or ECLIA, technology to detect and monitor various diseases and disorders through laboratory evaluation and analysis of blood, urine or other body fluids.

Source: Business Wire

More News in this Category